Top

Journal of Experimental & Clinical Cancer Research

Published in:

Open Access 01-12-2021 | Glioblastoma | Retraction Note

Retraction Note: Reprogramming glioblastoma multiforme cells into neurons by protein kinase inhibitors

Authors: Jie Yuan, Fan Zhang, Dennis Hallahan, Zhen Zhang, Liming He, Ling-Gang Wu, Meng You, Qin Yang

Published in: Journal of Experimental & Clinical Cancer Research | Issue 1/2021

Excerpt

Retraction Note: J Exp Clin Cancer Res 37, 181 (2018) …

Yuan J, Zhang F, You M, et al. Identification of protein kinase inhibitors to reprogram breast cancer cells. Cell Death Dis. 2018;9:915. https://doi.org/10.1038/s41419-018-1002-2.CrossRefPubMedPubMedCentral

Sun CK, Zhou D, Zhang Z, et al. Senescence impairs direct conversion of human somatic cells to neurons. Nat Commun. 2014;5:4112. https://doi.org/10.1038/ncomms5112.CrossRefPubMed

Title: Retraction Note: Reprogramming glioblastoma multiforme cells into neurons by protein kinase inhibitors
Authors: Jie Yuan
Fan Zhang
Dennis Hallahan
Zhen Zhang
Liming He
Ling-Gang Wu
Meng You
Qin Yang
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: Glioblastoma
Glioblastoma
Glioblastoma
Published in: Journal of Experimental & Clinical Cancer Research / Issue 1/2021
Electronic ISSN: 1756-9966
DOI: https://doi.org/10.1186/s13046-021-02172-6

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2021

Focal adhesion kinase inhibition synergizes with nab-paclitaxel to target pancreatic ductal adenocarcinoma

WNT11/ROR2 signaling is associated with tumor invasion and poor survival in breast cancer

Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth

LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2

Correction to: Forkhead box (FOX) G1 promotes hepatocellular carcinoma epithelial-Mesenchymal transition by activating Wnt signal through forming T-cell factor-4/Betacatenin/FOXG1 complex

Correction to: Combination therapy of PKCζ and COX-2 inhibitors synergistically suppress melanoma metastasis

Keynote webinar | Spotlight on antibody–drug conjugates in cancer